GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » EBITDA Margin %

RBC Bioscience (ROCO:6848) EBITDA Margin % : 23.50% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is RBC Bioscience EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. RBC Bioscience's EBITDA for the six months ended in Dec. 2023 was NT$19.6 Mil. RBC Bioscience's Revenue for the six months ended in Dec. 2023 was NT$83.5 Mil. Therefore, RBC Bioscience's EBITDA margin for the quarter that ended in Dec. 2023 was 23.50%.


RBC Bioscience EBITDA Margin % Historical Data

The historical data trend for RBC Bioscience's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RBC Bioscience EBITDA Margin % Chart

RBC Bioscience Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial 17.91 33.44 24.74 18.53 21.50

RBC Bioscience Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.76 23.40 11.58 19.61 23.50

Competitive Comparison of RBC Bioscience's EBITDA Margin %

For the Biotechnology subindustry, RBC Bioscience's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RBC Bioscience's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RBC Bioscience's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where RBC Bioscience's EBITDA Margin % falls into.



RBC Bioscience EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

RBC Bioscience's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=37.072/172.467
=21.50 %

RBC Bioscience's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=19.627/83.527
=23.50 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


RBC Bioscience  (ROCO:6848) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


RBC Bioscience EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


RBC Bioscience (ROCO:6848) Business Description

Traded in Other Exchanges
N/A
Address
Lane 235, Baoqiao Road, 3rd Floor, No. 132, New Taipei City, TWN, 23145
RBC Bioscience Corp is a bio sciences company. Its products include Real Genomics, MagCore Automated Nucleic Acid Extractor, and MagCore Nucleic Acid Extraction KIT.

RBC Bioscience (ROCO:6848) Headlines

No Headlines